Dynavax Technologies | Laba Sebelum Pajak





Laba Sebelum Pajak Perubahan Tanggal
AbbVie USD 4.38B 1.92B 2025-09
Adma Biologics USD 47.52M 7.42M 2025-09
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 3.92B 2.35B 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Dynavax Technologies USD 28.42M 7.2M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
Glaxosmithkline GBP 2.46B 569M 2025-09
Merck USD 6.74B 22M 2025-09
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Novartis USD 4.2B 335M 2025-09
Pfizer USD 3.33B 290M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
TG Therapeutics USD 25.91M 5.01M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Dynavax Technologies Laba Sebelum Pajak - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.